AxoGen (NASDAQ: AXGN) reported Q3 EPS of $0.01, $0.07 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $41.3 million versus the consensus estimate of $40.45 million.

For earnings history and earnings-related data on AxoGen (AXGN) click here.